 | • レポートコード：MRC2-11QY11721 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はドラッグリポジショニングのグローバル市場について調査・分析したレポートです。種類別（腫瘍、中枢神経系疾患、神経変性疾患、その他）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ドラッグリポジショニングの競争状況、市場シェア ・世界のドラッグリポジショニング市場：種類別市場規模 2015年-2020年（腫瘍、中枢神経系疾患、神経変性疾患、その他） ・世界のドラッグリポジショニング市場：種類別市場規模予測 2021年-2026年（腫瘍、中枢神経系疾患、神経変性疾患、その他） ・世界のドラッグリポジショニング市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界のドラッグリポジショニング市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米のドラッグリポジショニング市場分析：米国、カナダ ・ヨーロッパのドラッグリポジショニング市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのドラッグリポジショニング市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のドラッグリポジショニング市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのドラッグリポジショニング市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma、Biovista、Novartis、AbbVie、Pfizer、Allergan、NuMedii ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
Market Analysis and Insights: Global Drug Repurposing Market
The global Drug Repurposing market size is projected to reach US$ 25330 million by 2026, from US$ 24560 million in 2020, at a CAGR of 2.9%% during 2021-2026.
Global Drug Repurposing Scope and Market Size
Drug Repurposing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repurposing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
…
Market segment by Type, the product can be split into
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Repurposing Revenue
1.4 Market by Type
1.4.1 Global Drug Repurposing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oncology
1.4.3 CNS Diseases
1.4.4 Neurodegenerative Diseases
1.4.5 Others
1.5 Market by Application
1.5.1 Global Drug Repurposing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2015-2026)
2.2 Global Drug Repurposing Growth Trends by Regions
2.2.1 Drug Repurposing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug Repurposing Historic Market Share by Regions (2015-2020)
2.2.3 Drug Repurposing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Drug Repurposing Market Growth Strategy
2.3.6 Primary Interviews with Key Drug Repurposing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Market Size
3.1.1 Global Top Drug Repurposing Players by Revenue (2015-2020)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Repurposing Market Concentration Ratio
3.2.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2019
3.3 Drug Repurposing Key Players Head office and Area Served
3.4 Key Players Drug Repurposing Product Solution and Service
3.5 Date of Enter into Drug Repurposing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drug Repurposing Historic Market Size by Type (2015-2020)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Drug Repurposing Market Size by Application (2015-2020)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug Repurposing Market Size (2015-2020)
6.2 Drug Repurposing Key Players in North America (2019-2020)
6.3 North America Drug Repurposing Market Size by Type (2015-2020)
6.4 North America Drug Repurposing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Drug Repurposing Market Size (2015-2020)
7.2 Drug Repurposing Key Players in Europe (2019-2020)
7.3 Europe Drug Repurposing Market Size by Type (2015-2020)
7.4 Europe Drug Repurposing Market Size by Application (2015-2020)
8 China
8.1 China Drug Repurposing Market Size (2015-2020)
8.2 Drug Repurposing Key Players in China (2019-2020)
8.3 China Drug Repurposing Market Size by Type (2015-2020)
8.4 China Drug Repurposing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Drug Repurposing Market Size (2015-2020)
9.2 Drug Repurposing Key Players in Japan (2019-2020)
9.3 Japan Drug Repurposing Market Size by Type (2015-2020)
9.4 Japan Drug Repurposing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Drug Repurposing Market Size (2015-2020)
10.2 Drug Repurposing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Repurposing Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Repurposing Market Size by Application (2015-2020)
11 India
11.1 India Drug Repurposing Market Size (2015-2020)
11.2 Drug Repurposing Key Players in India (2019-2020)
11.3 India Drug Repurposing Market Size by Type (2015-2020)
11.4 India Drug Repurposing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Drug Repurposing Market Size (2015-2020)
12.2 Drug Repurposing Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Repurposing Market Size by Type (2015-2020)
12.4 Central & South America Drug Repurposing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astellas Pharma
13.1.1 Astellas Pharma Company Details
13.1.2 Astellas Pharma Business Overview
13.1.3 Astellas Pharma Drug Repurposing Introduction
13.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2015-2020))
13.1.5 Astellas Pharma Recent Development
13.2 Biovista
13.2.1 Biovista Company Details
13.2.2 Biovista Business Overview
13.2.3 Biovista Drug Repurposing Introduction
13.2.4 Biovista Revenue in Drug Repurposing Business (2015-2020)
13.2.5 Biovista Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Drug Repurposing Introduction
13.3.4 Novartis Revenue in Drug Repurposing Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 AbbVie
13.4.1 AbbVie Company Details
13.4.2 AbbVie Business Overview
13.4.3 AbbVie Drug Repurposing Introduction
13.4.4 AbbVie Revenue in Drug Repurposing Business (2015-2020)
13.4.5 AbbVie Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Drug Repurposing Introduction
13.5.4 Pfizer Revenue in Drug Repurposing Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Allergan
13.6.1 Allergan Company Details
13.6.2 Allergan Business Overview
13.6.3 Allergan Drug Repurposing Introduction
13.6.4 Allergan Revenue in Drug Repurposing Business (2015-2020)
13.6.5 Allergan Recent Development
13.7 NuMedii
13.7.1 NuMedii Company Details
13.7.2 NuMedii Business Overview
13.7.3 NuMedii Drug Repurposing Introduction
13.7.4 NuMedii Revenue in Drug Repurposing Business (2015-2020)
13.7.5 NuMedii Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Drug Repurposing Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Repurposing Revenue
Table 3. Ranking of Global Top Drug Repurposing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oncology
Table 6. Key Players of CNS Diseases
Table 7. Key Players of Neurodegenerative Diseases
Table 8. Key Players of Others
Table 9. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Drug Repurposing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Drug Repurposing Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Drug Repurposing Market Share by Regions (2015-2020)
Table 13. Global Drug Repurposing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Drug Repurposing Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Drug Repurposing Market Growth Strategy
Table 19. Main Points Interviewed from Key Drug Repurposing Players
Table 20. Global Drug Repurposing Revenue by Players (2015-2020) (Million US$)
Table 21. Global Drug Repurposing Market Share by Players (2015-2020)
Table 22. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2019)
Table 23. Global Drug Repurposing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Drug Repurposing Product Solution and Service
Table 26. Date of Enter into Drug Repurposing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 29. Global Drug Repurposing Market Size Share by Type (2015-2020)
Table 30. Global Drug Repurposing Revenue Market Share by Type (2021-2026)
Table 31. Global Drug Repurposing Market Size Share by Application (2015-2020)
Table 32. Global Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 33. Global Drug Repurposing Market Size Share by Application (2021-2026)
Table 34. North America Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Drug Repurposing Market Share (2019-2020)
Table 36. North America Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 37. North America Drug Repurposing Market Share by Type (2015-2020)
Table 38. North America Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 39. North America Drug Repurposing Market Share by Application (2015-2020)
Table 40. Europe Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Drug Repurposing Market Share (2019-2020)
Table 42. Europe Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Drug Repurposing Market Share by Type (2015-2020)
Table 44. Europe Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Drug Repurposing Market Share by Application (2015-2020)
Table 46. China Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 47. China Key Players Drug Repurposing Market Share (2019-2020)
Table 48. China Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 49. China Drug Repurposing Market Share by Type (2015-2020)
Table 50. China Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 51. China Drug Repurposing Market Share by Application (2015-2020)
Table 52. Japan Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Drug Repurposing Market Share (2019-2020)
Table 54. Japan Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Drug Repurposing Market Share by Type (2015-2020)
Table 56. Japan Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Drug Repurposing Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Drug Repurposing Market Share (2019-2020)
Table 60. Southeast Asia Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Drug Repurposing Market Share by Type (2015-2020)
Table 62. Southeast Asia Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Drug Repurposing Market Share by Application (2015-2020)
Table 64. India Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 65. India Key Players Drug Repurposing Market Share (2019-2020)
Table 66. India Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 67. India Drug Repurposing Market Share by Type (2015-2020)
Table 68. India Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 69. India Drug Repurposing Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Drug Repurposing Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Drug Repurposing Market Share (2019-2020)
Table 72. Central & South America Drug Repurposing Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Drug Repurposing Market Share by Type (2015-2020)
Table 74. Central & South America Drug Repurposing Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Drug Repurposing Market Share by Application (2015-2020)
Table 76. Astellas Pharma Company Details
Table 77. Astellas Pharma Business Overview
Table 78. Astellas Pharma Product
Table 79. Astellas Pharma Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 80. Astellas Pharma Recent Development
Table 81. Biovista Company Details
Table 82. Biovista Business Overview
Table 83. Biovista Product
Table 84. Biovista Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 85. Biovista Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Product
Table 94. AbbVie Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 95. AbbVie Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Product
Table 104. Allergan Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 105. Allergan Recent Development
Table 106. NuMedii Company Details
Table 107. NuMedii Business Overview
Table 108. NuMedii Product
Table 109. NuMedii Revenue in Drug Repurposing Business (2015-2020) (Million US$)
Table 110. NuMedii Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repurposing Market Share by Type: 2020 VS 2026
Figure 2. Oncology Features
Figure 3. CNS Diseases Features
Figure 4. Neurodegenerative Diseases Features
Figure 5. Others Features
Figure 6. Global Drug Repurposing Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Drug Repurposing Report Years Considered
Figure 11. Global Drug Repurposing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Drug Repurposing Market Share by Regions: 2020 VS 2026
Figure 13. Global Drug Repurposing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Drug Repurposing Market Share by Players in 2019
Figure 16. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2019
Figure 18. North America Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Drug Repurposing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…- ドラッグデリバリーシステム（DDS）の世界市場（～2026年） Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. Market Analysis and Insights: Global Drug Delivery Systems Market The global Drug Delivery Systems market size is projecte…
- 薬物・遺伝子送達システムの世界市場（～2026年） Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells. Market Ana…
- 埋め込み型ドラッグデリバリーシステム（DDS）の世界市場（～2026年） Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes n…
- がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…